An artificial neural network can reveal patterns in huge amounts of gene expression data, and discover groups of disease-related genes. This has been shown by a new study led by researchers at Linköping University. The scientists hope that the method can eventually be applied within precision medicine and individualised treatment.
It’s common when using social media that the platform suggests people whom you may want to add as friends. The suggestion is based on you and the other person having common contacts, which indicates that you may know each other. In a similar manner, scientists are creating maps of biological networks based on how different proteins or genes interact with each other. The researchers behind a new study have used artificial intelligence, AI, to investigate whether it is possible to discover biological networks using deep learning, in which entities known as “artificial neural networks” are trained by experimental data. Since artificial neural networks are excellent at learning how to find patterns in enormous amounts of complex data, they are used in applications such as image recognition. However, this machine learning method has until now seldom been used in biological research.
“We have for the first time used deep learning to find disease-related genes. This is a very powerful method in the analysis of huge amounts of biological information, or ‘big data’”, says Sanjiv Dwivedi, postdoc in the Department of Physics, Chemistry and Biology (IFM) at Linköping University.
The scientists used a large database with information about the expression patterns of 20,000 genes in a large number of people. The information was “unsorted”, in the sense that the researchers did not give the artificial neural network information about which gene expression patterns were from people with diseases, and which were from healthy people. The AI model was then trained to find patterns of gene expression.
One of the challenges of machine learning is that it is not possible to see exactly how an artificial neural network solves a task. AI is sometimes described as a “black box” – we see only the information that we put into the box and the result that it produces. We cannot see the steps between. Artificial neural networks consist of several layers in which information is mathematically processed. The network comprises an input layer and an output layer that delivers the result of the information processing carried out by the system. Between these two layers are several hidden layers in which calculations are carried out. When the scientists had trained the artificial neural network, they wondered whether it was possible to, in a manner of speaking, lift the lid of the black box and understand how it works. Are the designs of the neural network and the familiar biological networks similar?
“When we analysed our neural network, it turned out that the first hidden layer represented to a large extent interactions between various proteins. Deeper in the model, in contrast, on the third level, we found groups of different cell types. It’s extremely interesting that this type of biologically relevant grouping is automatically produced, given that our network has started from unclassified gene expression data”, says Mika Gustafsson, senior lecturer at IFM and leader of the study in Nature Communications.
The scientists then investigated whether their model of gene expression could be used to determine which gene expression patterns are associated with disease and which is normal. They confirmed that the model finds relevant patterns that agree well with biological mechanisms in the body. Since the model has been trained using unclassified data, it is possible that the artificial neural network has found totally new patterns. The researchers plan now to investigate whether such, previously unknown patterns, are relevant from a biological perspective.
“We believe that the key to progress in the field is to understand the neural network. This can teach us new things about biological contexts, such as diseases in which many factors interact. And we believe that our method gives models that are easier to generalise and that can be used for many different types of biological information”, says Mika Gustafsson.
Mika Gustafsson hopes that close collaboration with medical researchers will enable him to apply the method developed in the study in precision medicine. It may be possible, for example, to determine which groups of patients should receive a certain type of medicine, or identify the patients who are most severely affected.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
- Revealing the Genes that Shape the Human Brain
Neurologist Christopher Walsh discovered genes that direct cerebral cortex development. We asked him what they reveal about intelligence, psychiatric disorders, and the nature of being human ...
- Helping cells become better protein factories could improve gene therapies and other treatments – a new technique shows how
Gene therapies and vaccines are often injected into muscle cells that are inefficient at producing desired proteins. Making them work more like liver cells could lead to better treatment outcomes.
- Anavex Announces First Entire Clinical Alzheimer’s Gene Pathway Data of ANAVEX®2-73 at AAIC 2022
These findings will facilitate contextualization of upcoming readout of ANAVEX®2-73 Phase 2b/3 Alzheimer’s disease clinical trial NEW YORK, July 31, 2022 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp.
- Scientists Discover Genetic Clues Related to Treating Macular Degeneration
Better treatments for an eye condition that can cause blindness are a major step closer after scientists discovered genetic clues that show who has it. Researchers in Australia have unearthed genetic ...
- Gut disorders and Alzheimer's: Scientists find genetic link
A new study suggests that gut disorders may indicate a greater risk of developing Alzheimer's disease, strengthening theories around the gut-brain axis.
Go deeper with Google Headlines on:
Go deeper with Bing News on:
- Google backs $65M funding for precision medicine startup
Google's venture capital arm, GV, participated in the $65 million series A fundraising round for precision medicine startup Vicinitas Therapeutics. Vicinitas Therapeutics specializes in developing ...
- A better understanding of human diversity is needed to equitably advance precision medicine
Achieving the goal of precision medicine for all requires continued study of what makes humans different. But if diversity research has shown one thing, it is that what separates us is much less than ...
- Oncology Precision Medicine Market Size is projected to reach USD 124.84 billion by 2030, growing at a CAGR of 10.85%: Straits Research
The global market for Oncology Precision Medicine was estimated to be worth $49.4 billion in 2021, and it is expected to reach $ 124.84 billion by 2030, expanding at a CAGR of 10.85% from 2021 to 2030 ...
- Clinical Decision Support Tool Provides Effective Precision Medicine Guidance
Researchers have found that an automated tool for genetic disease diagnosis and management guidance can achieve accurate results within 13.5 hours.
- ACP offers guidance on the ethical use of genetic testing and precision medicine
A new position paper from the American College of Physicians (ACP) offers guidance regarding ethical decision-making for the integration of precision medicine and genetic testing into internal ...